ArticleAIDS and behavior2025
COVID-19 Pandemic's Impact on HIV and AIDS Case Reporting in Peru: A Time Series Analysis of Surveillance Data (1983-2023).
Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The HIV/AIDS Epidemiological Challenges: Why is HIV Incidence Rising While AIDS Incidence and Mortality are Declining in Brazil?Journal of community health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic substantially disrupted healthcare services worldwide, and its impact on the identification and reporting of HIV and AIDS cases has become a critical concern. This study evaluated the effects of the pandemic on HIV/AIDS surveillance in Peru through a natural experiment using interrupted time series analysis of national surveillance data. Analysis of trends from 1985 to 2023 for HIV and from 1983 to 2023 for AIDS revealed consistent pre-pandemic increases, with an average annual growth of 27.02% for HIV cases and 20.48% for AIDS cases. However, the onset of the pandemic in 2020 was associated with significant immediate declines, with reductions of 1,609.86 HIV cases (95% CI: -3,147.26 to - 72.46) and 1,187.68 AIDS cases (95% CI: -1,560.10 to - 815.26). Furthermore, comparisons against ARIMA forecasts (HIV accuracy = 84.80%, AIDS accuracy = 85.45%) indicated substantial underreporting during the 2020-2023 period-estimated at 15.77% for HIV and 29.03% for AIDS cases. These results underscore the adverse effect of the COVID-19 crisis on ongoing HIV/AIDS case detection and reporting in Peru. They also highlight the urgent need for robust strategies-such as expanding telemedicine, enhancing self-testing, and reinforcing community-based interventions-to ensure continuous access to diagnosis and treatment during public health emergencies.
Indexed as
Identifiers
40029579What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.